Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1231

1.

Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.

Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, Ajani J, Rich TA, Goswitz MS, Evetts PA, Allen PK, Lynch PM, Skibber JM.

Radiother Oncol. 1999 May;51(2):153-60.

PMID:
10435807
2.

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.

Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J.

Am J Clin Oncol. 2001 Apr;24(2):107-12.

PMID:
11319280
3.

Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.

Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, Cellini F, Barbaro B, Cogliandolo S, Nuzzo G, Doglietto GB, Ambesi-Impiombato F, Cosimelli M.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):664-74.

PMID:
12062610
4.

Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.

Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA, Skibber J.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1027-38.

PMID:
10421535
5.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
6.

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, Marino F, Ambrosi A, Lise M.

Dis Colon Rectum. 2004 Nov;47(11):1798-807.

PMID:
15622571
7.

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.

Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77.

PMID:
15708244
8.

T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.

Sanfilippo NJ, Crane CH, Skibber J, Feig B, Abbruzzese JL, Curley S, Vauthey JN, Ellis LM, Hoff P, Wolff RA, Brown TD, Cleary K, Wong A, Phan T, Janjan NA.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):176-83.

PMID:
11516868
9.

Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.

Movsas B, Hanlon AL, Lanciano R, Scher RM, Weiner LM, Sigurdson ER, Hoffman JP, Eisenberg BL, Cooper HS, Provins S, Coia LR.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):43-50.

PMID:
9747818
10.

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.

Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1098-105.

PMID:
15519780
11.

The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.

Lindebjerg J, Spindler KL, Ploen J, Jakobsen A.

Colorectal Dis. 2009 Mar;11(3):264-9. doi: 10.1111/j.1463-1318.2008.01599.x. Epub 2008 Jun 20.

PMID:
18573119
12.

T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.

Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS.

Dis Colon Rectum. 2002 Jul;45(7):895-903.

PMID:
12130878
13.

Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.

Mohiuddin M, Hayne M, Regine WF, Hanna N, Hagihara PF, McGrath P, Marks GM.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1075-80.

PMID:
11072165
14.

Locally advanced rectal carcinoma: preoperative radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized clinical study.

Taher AN, El-Baradie MM, Nasr AM, Khorshid O, Morsi A, Hamza MR, Mokhtar N, Ezzat S.

J Egypt Natl Canc Inst. 2006 Sep;18(3):233-43.

15.

The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.

Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, Lin EH, Fleshman JW, Thames HD, Kodner IJ, Lockett MA, Picus J, Phan T, Chandra A, Janjan NA, Read TE, Myerson RJ.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):84-9.

PMID:
12909219
16.

Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.

Cambray i Amenós M, Navarro García M, Martí Ragué J, Pareja Fernández L, Pera Fábregas J.

Clin Transl Oncol. 2007 Mar;9(3):183-91.

PMID:
17403630
17.

Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.

Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH.

Am J Clin Oncol. 2006 Jun;29(3):219-24.

PMID:
16755173
18.

The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy.

Beresford M, Glynne-Jones R, Richman P, Makris A, Mawdsley S, Stott D, Harrison M, Osborne M, Ashford R, Grainger J, Al-Jabbour J, Talbot I, Mitchell IC, Meyrick Thomas J, Livingstone JI, McCue J, MacDonald P, Northover JA, Windsor A, Novell R, Wallace M, Harrison RA.

Clin Oncol (R Coll Radiol). 2005 Sep;17(6):448-55.

PMID:
16149289
19.

Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.

Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG.

Dis Colon Rectum. 2002 Oct;45(10):1349-58.

PMID:
12394434
20.

A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.

Myerson RJ, Valentini V, Birnbaum EH, Cellini N, Coco C, Fleshman JW, Gambacorta MA, Genovesi D, Kodner IJ, Picus J, Ratkin GA, Read TE.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1299-308.

PMID:
11483342

Supplemental Content

Support Center